AAN 2026: How Identifying Genetic DEEs Within Existing Trial Data Could Expand the Role of Cannabidiol in Epilepsy TreatmentByElizabeth Thiele, MD, PhD,Kennedy Ferruggia, Associate EditorApril 22nd 2026Cannabidiol may have broader applicability across genetic developmental and epileptic encephalopathies (DEEs).